By: Christopher A. Parrella, Esq., CPC, CPCO, CHC

Parrella Health Law, Boston, Ma.

A Health Care Defense and Compliance Firm

In a groundbreaking legal settlement, Publicis Health, a leading global marketing and communications firm, has agreed to pay $350 million to settle allegations over its role in the opioid epidemic, marking a significant moment in the ongoing battle against opioid abuse and its devastating effects on communities across the United States. This settlement with all 50 states and the District of Columbia, announced by New York Attorney General Letitia James, is the first of its kind involving a healthcare advertising agency, highlighting the expanding scope of accountability for the opioid crisis beyond pharmaceutical manufacturers and distributors.

Publicis Health, formerly an advertising agency for Purdue Pharma, the maker of OxyContin, is accused of deploying “predatory and deceptive marketing strategies” that significantly exacerbated the opioid crisis. Between 2010 and 2019, Publicis Health is said to have developed marketing campaigns that not only promoted opioids like OxyContin but also targeted physicians to increase prescriptions and sales, contributing to an overprescription epidemic that has devastated countless lives.

The allegations against Publicis include the development of marketing materials that emphasized the “abuse-deterrent” properties of OxyContin, misleadingly suggesting safer use and encouraging prescriptions at higher doses for longer periods. This strategy, devised in conjunction with consultancy firms like McKinsey & Co., aimed at expanding opioid usage among patients, including those not medically appropriate for long-term opioid therapy.

Under the terms of the settlement, Publicis Health must pay the agreed amount to the states within 60 days and is prohibited from accepting future contracts for marketing opioids. Additionally, the company is required to release hundreds of thousands of internal documents detailing its work with Purdue Pharma and other opioid manufacturers, providing a clearer insight into the marketing strategies that fueled the opioid epidemic.

Publicis Health has denied the allegations, stating that the settlement is not an admission of wrongdoing or liability. The company argues that its marketing activities were fully compliant with the law at all times, emphasizing that the strategies in question were implemented by a subsidiary that has since been closed.